See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Adherex Technologies Inc. (ADH)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ADH
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on ADH
Centient Biotech Investor
(10 followers)
Biotech Day In Review: Amgen Hit with SEC Investigation
(Thu, Mar 1)
Biotech Stocks Day-In-Review: Adherex Buys Out GSK Option
(Fri, Jan 19)
More by Centient Biotech Investor on ADH »
Microcap Speculator
(285 followers)
Reader's Micro-Cap Pick: Oxigene (OXGN)
(Mon, Feb 13)
More by Microcap Speculator on ADH »
Most followed authors on ADH
Microcap Speculator
(285 followers)
Reader's Micro-Cap Pick: Oxigene (OXGN)
(Mon, Feb 13)
More by Microcap Speculator on ADH »
Centient Biotech Investor
(10 followers)
Biotech Day In Review: Amgen Hit with SEC Investigation
(Thu, Mar 1)
Biotech Stocks Day-In-Review: Adherex Buys Out GSK Option
(Fri, Jan 19)
More by Centient Biotech Investor on ADH »
Newest authors on ADH
Centient Biotech Investor
(10 followers)
Biotech Day In Review: Amgen Hit with SEC Investigation
(Thu, Mar 1)
Biotech Stocks Day-In-Review: Adherex Buys Out GSK Option
(Fri, Jan 19)
More by Centient Biotech Investor on ADH »
Microcap Speculator
(285 followers)
Reader's Micro-Cap Pick: Oxigene (OXGN)
(Mon, Feb 13)
More by Microcap Speculator on ADH »
Most commented on ADH
Centient Biotech Investor
(10 followers)
Biotech Day In Review: Amgen Hit with SEC Investigation
(Thu, Mar 1)
Biotech Stocks Day-In-Review: Adherex Buys Out GSK Option
(Fri, Jan 19)
More by Centient Biotech Investor on ADH »